Form 4: TELA Bio Director Burgess Acquires Stock Options and Restricted Stock Units

Director Vincent J. Burgess acquired stock options and restricted stock units in TELA Bio, Inc.

Summary

• On June 4, 2024, Vincent J. Burgess, a director of TELA Bio, Inc., acquired 4,250 shares of common stock and stock options for 6,200 shares.
• The restricted stock units vest on the earlier of June 4, 2025, the next annual meeting of stockholders, or a Change in Control, subject to continued service.
• The stock options, with an exercise price of $5.71, also vest on the earlier of June 4, 2025, the next annual meeting of stockholders, or a Change in Control, subject to continued service.
• Following the transaction, Burgess directly owns 15,380 shares of common stock and options for 6,200 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying or option grants are generally viewed favorably, but the impact is limited as it's a standard compensation practice.

Positives

• The acquisition of stock options and restricted stock units by a director could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting of the restricted stock units and stock options is contingent upon continued service and could be accelerated by a change in control.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Stakeholder Impact

• The acquisition of stock options and restricted stock units by a director could positively influence shareholder sentiment.

Key Dates